GEN Exclusives

More »

GEN News Highlights

More »
Aug 23, 2012

Flick a Switch to Burn More Fat

  • The discovery of a molecular switch that can be manipulated to boost the activity of enzymes responsible for burning fat may one day lead to new treatments for obesity and potentially a host of disorders ranging from cardiovascular disease to stroke and skin problems, researchers claim. Using a lipase enzyme model system devised in collaboration with colleagues at Novozymes, a multidisciplinary team at the University of Copenhagen has found that the lipase enzyme (Thermomyces lanuginosus lipase in this case) can adopt a slightly different functional state that effectively makes it work harder. In essence, by tripping the switch, the researchers were able to make the lipase burn far more fat.

    The University of Copenhagen’s Dimitrios Stamou, Ph.D, and Nikos Hatzakis, Ph.D., hope that if this same activity-boosting switch is common to and can also be triggered in other enzymes, it may provide new therapeutic opportunities for a host of diseases. “Changing the fundamental shape of a tool is always difficult,” comments Dr. Hatzakis. “But working longer hours with the same tool is infinitely easier. What we’ve achieved is to make enzymes work longer hours.”

    The researchers report their findings in the Journal of the American Chemical Society. The paper is titled “Single Enzyme Studies Reveal the Existence of Discrete Functional States for Monomeric Enzymes and How They Are 'Selected' upon Allosteric Regulation.”

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »